1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Tochio, N. Koshiba, S. Inoue, M. Kigawa, T. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 The solution structure of the second thioredoxin-like domain of human Protein disulfide-isomerase 10.2210/pdb1x5c/pdb pdb_00001x5c 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 13251.812 Protein disulfide-isomerase 5.3.4.1 Thioredoxin like domain 1 man polymer PDI, Prolyl 4- hydroxylase beta subunit, Cellular thyroid hormone binding protein, p55 no no GSSGSSGPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSF PTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQSGPSSG GSSGSSGPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSF PTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQSGPSSG A hss001002456.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis P4HB 9606 Homo sapiens PLASMID P040628-09 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2005-11-15 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Y PDBJ Y PDBJ 2005-05-15 REL REL target function,structures with the least restraint violations 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 296 K torsion angle dynamics 1 lowest energy 1.2mM thioredoxin like domain U-15N,13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 3.5 Delaglio, F. processing NMRPipe 20031121 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.9044 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 900 Bruker AVANCE GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A PRO 8 n 8 PRO 8 A VAL 9 n 9 VAL 9 A LYS 10 n 10 LYS 10 A VAL 11 n 11 VAL 11 A LEU 12 n 12 LEU 12 A VAL 13 n 13 VAL 13 A GLY 14 n 14 GLY 14 A LYS 15 n 15 LYS 15 A ASN 16 n 16 ASN 16 A PHE 17 n 17 PHE 17 A GLU 18 n 18 GLU 18 A ASP 19 n 19 ASP 19 A VAL 20 n 20 VAL 20 A ALA 21 n 21 ALA 21 A PHE 22 n 22 PHE 22 A ASP 23 n 23 ASP 23 A GLU 24 n 24 GLU 24 A LYS 25 n 25 LYS 25 A LYS 26 n 26 LYS 26 A ASN 27 n 27 ASN 27 A VAL 28 n 28 VAL 28 A PHE 29 n 29 PHE 29 A VAL 30 n 30 VAL 30 A GLU 31 n 31 GLU 31 A PHE 32 n 32 PHE 32 A TYR 33 n 33 TYR 33 A ALA 34 n 34 ALA 34 A PRO 35 n 35 PRO 35 A TRP 36 n 36 TRP 36 A CYS 37 n 37 CYS 37 A GLY 38 n 38 GLY 38 A HIS 39 n 39 HIS 39 A CYS 40 n 40 CYS 40 A LYS 41 n 41 LYS 41 A GLN 42 n 42 GLN 42 A LEU 43 n 43 LEU 43 A ALA 44 n 44 ALA 44 A PRO 45 n 45 PRO 45 A ILE 46 n 46 ILE 46 A TRP 47 n 47 TRP 47 A ASP 48 n 48 ASP 48 A LYS 49 n 49 LYS 49 A LEU 50 n 50 LEU 50 A GLY 51 n 51 GLY 51 A GLU 52 n 52 GLU 52 A THR 53 n 53 THR 53 A TYR 54 n 54 TYR 54 A LYS 55 n 55 LYS 55 A ASP 56 n 56 ASP 56 A HIS 57 n 57 HIS 57 A GLU 58 n 58 GLU 58 A ASN 59 n 59 ASN 59 A ILE 60 n 60 ILE 60 A VAL 61 n 61 VAL 61 A ILE 62 n 62 ILE 62 A ALA 63 n 63 ALA 63 A LYS 64 n 64 LYS 64 A MET 65 n 65 MET 65 A ASP 66 n 66 ASP 66 A SER 67 n 67 SER 67 A THR 68 n 68 THR 68 A ALA 69 n 69 ALA 69 A ASN 70 n 70 ASN 70 A GLU 71 n 71 GLU 71 A VAL 72 n 72 VAL 72 A GLU 73 n 73 GLU 73 A ALA 74 n 74 ALA 74 A VAL 75 n 75 VAL 75 A LYS 76 n 76 LYS 76 A VAL 77 n 77 VAL 77 A HIS 78 n 78 HIS 78 A SER 79 n 79 SER 79 A PHE 80 n 80 PHE 80 A PRO 81 n 81 PRO 81 A THR 82 n 82 THR 82 A LEU 83 n 83 LEU 83 A LYS 84 n 84 LYS 84 A PHE 85 n 85 PHE 85 A PHE 86 n 86 PHE 86 A PRO 87 n 87 PRO 87 A ALA 88 n 88 ALA 88 A SER 89 n 89 SER 89 A ALA 90 n 90 ALA 90 A ASP 91 n 91 ASP 91 A ARG 92 n 92 ARG 92 A THR 93 n 93 THR 93 A VAL 94 n 94 VAL 94 A ILE 95 n 95 ILE 95 A ASP 96 n 96 ASP 96 A TYR 97 n 97 TYR 97 A ASN 98 n 98 ASN 98 A GLY 99 n 99 GLY 99 A GLU 100 n 100 GLU 100 A ARG 101 n 101 ARG 101 A THR 102 n 102 THR 102 A LEU 103 n 103 LEU 103 A ASP 104 n 104 ASP 104 A GLY 105 n 105 GLY 105 A PHE 106 n 106 PHE 106 A LYS 107 n 107 LYS 107 A LYS 108 n 108 LYS 108 A PHE 109 n 109 PHE 109 A LEU 110 n 110 LEU 110 A GLU 111 n 111 GLU 111 A SER 112 n 112 SER 112 A GLY 113 n 113 GLY 113 A GLY 114 n 114 GLY 114 A GLN 115 n 115 GLN 115 A SER 116 n 116 SER 116 A GLY 117 n 117 GLY 117 A PRO 118 n 118 PRO 118 A SER 119 n 119 SER 119 A SER 120 n 120 SER 120 A GLY 121 n 121 GLY 121 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 10 A N LYS 10 A O LYS 64 A O LYS 64 A O VAL 61 A O VAL 61 A N ASN 27 A N ASN 27 A N PHE 32 A N PHE 32 A O THR 82 A O THR 82 A N PHE 85 A N PHE 85 A O ILE 95 A O ILE 95 1 A SER 3 -161.78 108.36 1 A SER 5 -130.22 -48.13 1 A SER 6 -41.36 159.78 1 A HIS 57 -66.95 -175.39 1 A ALA 88 -63.41 74.70 1 A ARG 92 -92.10 37.40 1 A ASN 98 -112.69 50.10 1 A GLU 111 -38.72 -35.90 2 A SER 5 -96.77 43.31 2 A HIS 39 -39.28 -33.92 2 A HIS 57 -66.89 -176.31 2 A ALA 88 -83.14 40.45 2 A ARG 92 -93.79 49.75 2 A GLU 111 -38.94 -37.91 3 A CYS 37 -57.21 109.44 3 A HIS 57 -66.26 -174.81 3 A ARG 92 34.34 46.42 3 A GLU 111 -36.53 -38.82 3 A SER 120 -134.47 -57.86 4 A SER 2 -61.56 89.32 4 A SER 5 -101.69 44.85 4 A ALA 21 -92.28 -63.75 4 A CYS 37 -58.66 103.70 4 A HIS 57 -65.01 -175.02 4 A SER 89 -35.28 140.64 4 A ARG 92 -85.63 40.00 4 A GLU 111 -38.01 -38.83 5 A HIS 57 -66.11 -174.71 5 A ALA 88 -77.96 47.29 5 A GLU 111 -37.35 -37.94 5 A SER 119 -35.49 113.43 6 A SER 6 -64.91 96.53 6 A HIS 57 -68.24 -174.36 6 A ARG 101 74.50 46.45 6 A GLU 111 -36.57 -36.58 6 A PRO 118 -69.75 2.84 7 A HIS 57 -65.84 -173.52 7 A ARG 92 34.30 42.35 7 A GLU 111 -38.35 -37.97 7 A SER 120 -95.89 41.75 8 A SER 6 -38.82 -38.45 8 A HIS 57 -64.48 -174.74 8 A ARG 92 31.98 53.46 8 A GLU 111 -37.36 -36.53 8 A SER 119 -121.91 -55.78 9 A HIS 39 -39.35 -38.31 9 A HIS 57 -66.00 -174.88 9 A ASP 91 -90.95 34.61 9 A ARG 92 35.94 42.81 9 A ARG 101 74.43 45.84 9 A GLU 111 -36.59 -38.71 9 A PRO 118 -69.81 4.95 10 A HIS 57 -67.53 -175.99 10 A ARG 92 37.14 47.25 10 A SER 116 -175.18 134.18 10 A SER 119 -48.89 155.11 11 A SER 2 -116.50 50.86 11 A HIS 57 -64.29 -174.68 11 A ALA 88 -75.75 48.91 11 A ASP 91 -99.66 38.95 11 A ARG 92 36.20 38.56 11 A SER 116 -173.00 129.46 12 A SER 2 -58.04 97.77 12 A HIS 57 -68.96 -174.54 12 A ASP 91 -84.70 34.77 12 A ARG 92 34.06 48.94 12 A GLU 111 -37.86 -38.76 12 A SER 116 -107.02 -60.95 12 A SER 119 -125.38 -55.80 12 A SER 120 38.44 42.01 13 A SER 5 -170.04 140.57 13 A HIS 57 -67.90 -174.42 13 A ALA 88 -66.97 84.45 13 A ALA 90 -49.13 -18.56 13 A GLU 111 -37.61 -34.90 14 A CYS 37 -60.00 106.50 14 A HIS 57 -66.80 -175.04 14 A ARG 92 28.57 47.82 14 A ARG 101 73.21 44.08 15 A SER 6 -91.53 43.99 15 A HIS 57 -62.21 -174.33 15 A ASP 91 -91.90 32.49 15 A ARG 92 33.25 39.89 16 A HIS 57 -67.98 -176.26 16 A ALA 88 -78.62 48.38 16 A ALA 90 -86.80 31.07 16 A SER 119 -47.13 155.67 17 A HIS 57 -64.12 -175.20 17 A ARG 92 35.38 35.70 18 A HIS 57 -64.15 -175.08 18 A ALA 88 -62.03 80.36 18 A ARG 92 35.42 54.52 18 A ASN 98 -118.71 51.38 18 A GLU 111 -38.25 -39.26 18 A PRO 118 -69.69 98.67 19 A ALA 21 -91.72 -63.83 19 A HIS 57 -63.99 -175.61 19 A ARG 92 -98.76 40.21 19 A GLN 115 -52.11 108.32 20 A PHE 22 -81.96 48.68 20 A LYS 25 48.87 28.62 20 A HIS 57 -63.50 -175.82 20 A ALA 88 -81.78 42.24 20 A ARG 92 35.33 50.57 20 A PRO 118 -69.79 80.94 20 A SER 120 37.71 40.73 The solution structure of the second thioredoxin-like domain of human Protein disulfide-isomerase 1 N N A ASN 16 A ASN 16 HELX_P A ALA 21 A ALA 21 1 1 6 A CYS 37 A CYS 37 HELX_P A GLU 52 A GLU 52 1 2 16 A THR 53 A THR 53 HELX_P A LYS 55 A LYS 55 5 3 3 A THR 102 A THR 102 HELX_P A GLY 113 A GLY 113 1 4 12 ISOMERASE DSI, ERBA2L, GIT, PDI, PDIA1, PO4DB, PO4HB, PROHB, thioredoxin like domain, redox, structural genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, ISOMERASE A PHE 80 A PHE 80 1 A PRO 81 A PRO 81 0.03 A PHE 80 A PHE 80 2 A PRO 81 A PRO 81 0.03 A PHE 80 A PHE 80 3 A PRO 81 A PRO 81 -0.04 A PHE 80 A PHE 80 4 A PRO 81 A PRO 81 0.02 A PHE 80 A PHE 80 5 A PRO 81 A PRO 81 0.07 A PHE 80 A PHE 80 6 A PRO 81 A PRO 81 0.03 A PHE 80 A PHE 80 7 A PRO 81 A PRO 81 0.06 A PHE 80 A PHE 80 8 A PRO 81 A PRO 81 -0.04 A PHE 80 A PHE 80 9 A PRO 81 A PRO 81 0.02 A PHE 80 A PHE 80 10 A PRO 81 A PRO 81 0.03 A PHE 80 A PHE 80 11 A PRO 81 A PRO 81 0.00 A PHE 80 A PHE 80 12 A PRO 81 A PRO 81 0.00 A PHE 80 A PHE 80 13 A PRO 81 A PRO 81 0.07 A PHE 80 A PHE 80 14 A PRO 81 A PRO 81 0.04 A PHE 80 A PHE 80 15 A PRO 81 A PRO 81 -0.03 A PHE 80 A PHE 80 16 A PRO 81 A PRO 81 0.04 A PHE 80 A PHE 80 17 A PRO 81 A PRO 81 0.01 A PHE 80 A PHE 80 18 A PRO 81 A PRO 81 0.02 A PHE 80 A PHE 80 19 A PRO 81 A PRO 81 0.04 A PHE 80 A PHE 80 20 A PRO 81 A PRO 81 0.01 PDIA1_HUMAN UNP 1 368 P07237 PVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFP ASADRTVIDYNGERTLDGFKKFLESGGQ 368 475 1X5C 8 115 P07237 A 1 8 115 1 cloning artifact GLY 1 1X5C A P07237 UNP 1 1 cloning artifact SER 2 1X5C A P07237 UNP 2 1 cloning artifact SER 3 1X5C A P07237 UNP 3 1 cloning artifact GLY 4 1X5C A P07237 UNP 4 1 cloning artifact SER 5 1X5C A P07237 UNP 5 1 cloning artifact SER 6 1X5C A P07237 UNP 6 1 cloning artifact GLY 7 1X5C A P07237 UNP 7 1 cloning artifact SER 116 1X5C A P07237 UNP 116 1 cloning artifact GLY 117 1X5C A P07237 UNP 117 1 cloning artifact PRO 118 1X5C A P07237 UNP 118 1 cloning artifact SER 119 1X5C A P07237 UNP 119 1 cloning artifact SER 120 1X5C A P07237 UNP 120 1 cloning artifact GLY 121 1X5C A P07237 UNP 121 5 parallel parallel anti-parallel anti-parallel A LYS 10 A LYS 10 A LEU 12 A LEU 12 A ILE 60 A ILE 60 A ASP 66 A ASP 66 A ASN 27 A ASN 27 A TYR 33 A TYR 33 A THR 82 A THR 82 A PHE 86 A PHE 86 A ILE 95 A ILE 95 A ASP 96 A ASP 96